EU regulator warns of insufficient data on inhaled steroids to treat Covid-19
The European Medicines Agency said although its Covid-19 taskforce had not found any safety risks so far for the corticosteroids, it could not exclude the possibility of harm in patients who have normal oxygen levels
Photo: REUTERS
Europe's medicines regulator said on Thursday there was insufficient evidence to support use of inhaled corticosteroids to treat patients with Covid-19, but said there was enough data at present to continue usage of dexamethasone.
The European Medicines Agency said although its Covid-19 taskforce had not found any safety risks so far for the corticosteroids, it could not exclude the possibility of harm in patients who have normal oxygen levels.
Keep updated, follow The Business Standard's Google news channel
